Discontinued — last reported Q4 '23

Other

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2023

How to read this metric

A high number of outstanding awards indicates potential for future share dilution, which may impact earnings per share calculations.

Detailed definition

This metric tracks the total number of outstanding share-based payment awards, including options, that are either vested...

Peer comparison

Standard metric for assessing dilution risk; peers in financial services report this in their equity incentive plan disclosures.

Metric ID: other_share_based_compensation_arrangement_by_share_base_25b35b

Historical Data

1 periods
 Q1 '26
Value$6.77M

Frequently Asked Questions

What is Medline, Inc. 's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
Medline, Inc. (MDLN) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $6.77M in Q1 2026.
What does share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number mean?
The total number of stock awards outstanding that employees have earned or are expected to earn.